Acebutolol
- Generic Name
- Acebutolol
- Brand Names
- Sectral
- Drug Type
- Small Molecule
- Chemical Formula
- C18H28N2O4
- CAS Number
- 37517-30-9
- Unique Ingredient Identifier
- 67P356D8GH
- Background
A cardioselective beta-adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm as well as weak inherent sympathomimetic action.
- Indication
For the management of hypertension and ventricular premature beats in adults.
- Associated Conditions
- Chronic Stable Angina Pectoris, Hypertension, Ventricular Arrhythmia
- Associated Therapies
- -
Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile Hemangioma
- First Posted Date
- 2012-12-06
- Last Posted Date
- 2016-06-01
- Lead Sponsor
- University Hospital, Montpellier
- Target Recruit Count
- 55
- Registration Number
- NCT01743885
- Locations
- 🇫🇷
Chirurgy Plastic Department, Montpellier, France
🇫🇷UH Lyon, Lyon, France
🇫🇷UH NCaremeau, Nîmes, France
An Open-label, Single-dose, Two-treatment, Randomized, Cross-over Study to Investigate the Effects of the SLCO2B1 c.1457C>T Polymorphism and Apple Juice on the Pharmacokinetics and Pharmacodynamics of Acebutolol in Healthy Korean and Japanese Volunteers
- First Posted Date
- 2012-01-20
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- In-Jin Jang, MD, PhD
- Target Recruit Count
- 16
- Registration Number
- NCT01514019
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇯🇵General Clinical Research Center, Oita University Hospital, Oita, Japan
Treatment of Mild Hypertension Study (TOMHS)
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- University of Minnesota
- Registration Number
- NCT00000522
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath